CA2041268A1 - Peptides with a bradykinin-antagonistic action - Google Patents
Peptides with a bradykinin-antagonistic actionInfo
- Publication number
- CA2041268A1 CA2041268A1 CA002041268A CA2041268A CA2041268A1 CA 2041268 A1 CA2041268 A1 CA 2041268A1 CA 002041268 A CA002041268 A CA 002041268A CA 2041268 A CA2041268 A CA 2041268A CA 2041268 A1 CA2041268 A1 CA 2041268A1
- Authority
- CA
- Canada
- Prior art keywords
- bradykinin
- peptides
- amino acid
- antagonistic action
- direct bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Peptides with a bradykinin-antagonistic action Peptides of the formula I
A-B-C-E-F-K-(D)-Tic-G-M-F'-I ~~(I) in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulfonyl, cycloalkyl, aryl, arylsulfonyl, heteroaryl or an amino acid, each of which can optionally be substi-tuted, B is a basic amino acid, C is a di- or tripeptide E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or a direct bond, G is an amino acid, F' is as defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO- or is a direct bond, have a bradykinin-antagonistic action.
Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin or bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
A-B-C-E-F-K-(D)-Tic-G-M-F'-I ~~(I) in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulfonyl, cycloalkyl, aryl, arylsulfonyl, heteroaryl or an amino acid, each of which can optionally be substi-tuted, B is a basic amino acid, C is a di- or tripeptide E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or a direct bond, G is an amino acid, F' is as defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO- or is a direct bond, have a bradykinin-antagonistic action.
Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin or bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP4013270.6 | 1990-04-26 | ||
| DE4013270A DE4013270A1 (en) | 1990-04-26 | 1990-04-26 | PEPTIDES WITH BRADYKININ ANTAGONISTIC EFFECT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2041268A1 true CA2041268A1 (en) | 1991-10-27 |
| CA2041268C CA2041268C (en) | 2001-10-02 |
Family
ID=6405107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002041268A Expired - Lifetime CA2041268C (en) | 1990-04-26 | 1991-04-25 | Peptides with a bradykinin-antagonistic action |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0455133B1 (en) |
| JP (1) | JP2552402B2 (en) |
| KR (1) | KR100195569B1 (en) |
| CN (1) | CN1034416C (en) |
| AT (1) | ATE149519T1 (en) |
| AU (1) | AU641004B2 (en) |
| CA (1) | CA2041268C (en) |
| CY (1) | CY2113B1 (en) |
| CZ (1) | CZ280682B6 (en) |
| DE (2) | DE4013270A1 (en) |
| DK (1) | DK0455133T3 (en) |
| ES (1) | ES2099102T3 (en) |
| FI (1) | FI109541B (en) |
| GR (1) | GR3023172T3 (en) |
| HK (1) | HK1006843A1 (en) |
| HU (1) | HU208028B (en) |
| IE (1) | IE911387A1 (en) |
| IL (1) | IL97944A (en) |
| LV (1) | LV10290B (en) |
| NO (1) | NO300779B1 (en) |
| NZ (1) | NZ237928A (en) |
| PT (1) | PT97466B (en) |
| RU (1) | RU2056432C1 (en) |
| SK (1) | SK279286B6 (en) |
| ZA (1) | ZA913121B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2106677A1 (en) * | 1991-04-01 | 1992-10-02 | John C. Cheronis | Bradykinin antagonists |
| TW199863B (en) * | 1991-12-21 | 1993-02-11 | Hoechst Ag | |
| TW258739B (en) * | 1992-04-04 | 1995-10-01 | Hoechst Ag | |
| EP0813544B1 (en) * | 1994-03-09 | 2004-10-27 | Cortech, Inc. | Bradykinin antagonist peptides incorporating n-substituted glycines |
| FR2739553B1 (en) * | 1995-10-06 | 1998-01-02 | Oreal | USE OF BRADYKININE ANTAGONISTS TO STIMULATE OR INDUCE HAIR GROWTH AND / OR STOP THE HAIR LOSS |
| DE19612067A1 (en) * | 1996-03-27 | 1997-10-02 | Hoechst Ag | Use of bradykinin antagonists for the manufacture of medicaments for the treatment of chronic fibrogenetic liver diseases and acute liver diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923963A (en) * | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
| DE3926822A1 (en) * | 1989-08-14 | 1991-02-21 | Hoechst Ag | PEPTIDES WITH BRADYKININ ANTAGONISTIC EFFECT |
| IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
-
1990
- 1990-04-26 DE DE4013270A patent/DE4013270A1/en not_active Withdrawn
-
1991
- 1991-04-24 FI FI911978A patent/FI109541B/en active
- 1991-04-24 NZ NZ237928A patent/NZ237928A/en unknown
- 1991-04-24 CZ CS911165A patent/CZ280682B6/en not_active IP Right Cessation
- 1991-04-24 AU AU75304/91A patent/AU641004B2/en not_active Expired
- 1991-04-24 SK SK1165-91A patent/SK279286B6/en not_active IP Right Cessation
- 1991-04-24 IL IL9794491A patent/IL97944A/en not_active IP Right Cessation
- 1991-04-24 PT PT97466A patent/PT97466B/en not_active IP Right Cessation
- 1991-04-25 KR KR1019910006649A patent/KR100195569B1/en not_active IP Right Cessation
- 1991-04-25 HU HU911392A patent/HU208028B/en unknown
- 1991-04-25 CA CA002041268A patent/CA2041268C/en not_active Expired - Lifetime
- 1991-04-25 JP JP3121848A patent/JP2552402B2/en not_active Expired - Lifetime
- 1991-04-25 ZA ZA913121A patent/ZA913121B/en unknown
- 1991-04-25 DK DK91106663.7T patent/DK0455133T3/en active
- 1991-04-25 CN CN91102638A patent/CN1034416C/en not_active Expired - Lifetime
- 1991-04-25 EP EP91106663A patent/EP0455133B1/en not_active Expired - Lifetime
- 1991-04-25 DE DE59108573T patent/DE59108573D1/en not_active Expired - Lifetime
- 1991-04-25 NO NO911649A patent/NO300779B1/en not_active IP Right Cessation
- 1991-04-25 AT AT91106663T patent/ATE149519T1/en not_active IP Right Cessation
- 1991-04-25 IE IE138791A patent/IE911387A1/en unknown
- 1991-04-25 ES ES91106663T patent/ES2099102T3/en not_active Expired - Lifetime
-
1992
- 1992-07-27 RU SU925052268A patent/RU2056432C1/en active
- 1992-12-23 LV LVP-92-699A patent/LV10290B/en unknown
-
1997
- 1997-04-18 GR GR970400829T patent/GR3023172T3/en unknown
-
1998
- 1998-06-22 HK HK98105879A patent/HK1006843A1/en not_active IP Right Cessation
- 1998-09-29 CY CY9800030A patent/CY2113B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO177597C (en) | Analogous Process for Preparing a Therapeutically Active Peptide with Bradykinin Antagonistic Effect | |
| NO178433C (en) | Analogous Process for Preparation of Therapeutically Active Peptide with Bradykin Antagonistic Effect | |
| CA2041268A1 (en) | Peptides with a bradykinin-antagonistic action |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |